Positive statistical correlations were identified between TeaRx™ diagnostic parameters and widely used benchmark tests for dry eye syndrome BioLight Life Sciences Investments Ltd. (OTC: BLGTY, TASE: BOLT), a firm that invests in, manages and commercializes biomedical i…
Source: Study identifies correlations between BioLight’s TeaRx diagnostic parameters and benchmark tests for dry eye syndrome
Tuesday, February 3, 2015
Study identifies correlations between BioLight’s TeaRx diagnostic parameters and benchmark tests for dry eye syndrome
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment